πŸ‡ΊπŸ‡Έ FDA
Patent

US 10703816

M971 chimeric antigen receptors

granted A61KA61K2239/31A61K40/11

Quick answer

US patent 10703816 (M971 chimeric antigen receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2239/31, A61K40/11, A61K40/31, A61K40/4211